The Recall Desk
SevereFDA (Drugs)·D-0478-2025·Announced 2025-07-02

NAD+ Pre-Filled Syringes Recalled for Lack of Sterility Assurance

Thrive Health Solutions is recalling NAD+ 100mg/mL pre-filled syringes (Lot #O-O8A01-25) distributed nationwide due to lack of assurance of sterility. Consumers should not use this product.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The FDA classified this as a Class II recall. Lack of sterility assurance in injectable products poses a significant risk of serious adverse health consequences, including infection, even though no reported illnesses are mentioned in the source text.

Plain-English summary

Thrive Health and Wellness, LLC, dba Thrive Health Solutions, is recalling NAD+ 100mg/mL pre-filled syringes due to lack of assurance of sterility. The affected product is a 16-syringe package with Lot #O-O8A01-25 and expiration date 3/7/2025, manufactured by Thrive Health Solutions located at 88 Inverness Circle East, Suite A-204, Englewood, Colorado 80112.

The product was distributed nationwide in the United States. Consumers who have purchased this product should not use it and should contact Thrive Health Solutions or consult their healthcare provider for guidance on next steps.

The recalled product

Product
Nicotinamide adenine dinucleotide (NAD+): 100mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112
Manufacturer
Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)
Hazard
  • lack-of-sterility-assurance
  • infection-risk

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot #: O-O8A01-25
  • Exp 3/7/2025

Distribution

Distributed nationwide across the United States.